ERMAFT 0,75 mg


Tablet 2s
scheduling status
S2
registration number
48/21.8.2/1033
What ERMAFT 0,75 mg is and what it is used for
Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraceptive method. ERMAFT is intended for emergencies only and is completely unsuitable for regular contraception. Its reliability is not as high as that of the familiar “pill”, which is taken for at least 21 days of the menstrual cycle.
dosage
Take 2 tablets in a single administration as soon as possible, preferably within 12 hours, but not later than 72 hours after unprotected sexual intercourse.
how to take
For oral administration.
What ERMAFT 0,75 mg contains
Each tablet of ERMAFT 0,75 mg contains 0,75 mg of levonorgestrel (micronized).
other ingredients
Croscarmellose sodium, Lactose monohydrate, magnesium stearate, poloxamer 188, microcrystalline cellulose. Contains sugar: Lactose monohydrate 44,0 mg.
Therapeutic classification
G03AD01 (A 21.8.2 Progesterones with or without oestrogens).
© 2026 SAHPRA. ALL RIGHTS RESERVED